Journal of Ophthalmology / 2019 / Article / Tab 2

Review Article

Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life

Table 2

Comparison of the data between baseline and the follow-up by using ANOVA test and the Bonferroni post hoc test.

Baseline1 month3 monthsBaseline vs. 1 month1 month vs. 3 monthsBaseline vs. 3 months
Mean (SD)Mean (SD)Mean (SD) value value value

Eyelid erythema0.46 (0.82)0.23 (0.55)0.13 (0.37)<0.001<0.001<0.001
Conjunctival hyperaemia0.97 (0.94)0.58 (0.64)0.33 (0.52)<0.001<0.001<0.001
Follicular hyperplasia0.36 (0.62)0.16 (0.40)0.08 (0.31)<0.001<0.001<0.001
Beak-up time (sec)9.82 (0.31)10.9 (3.24)11.5 (3.38)<0.001<0.001<0.001
Schirmer test (min)13.46 (6.28)14.72 (6.44)15.41 (6.32)<0.001<0.001<0.001

From [95].

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.